Pseudomonas aeruginosa: Current & Future Treatment Options

Marin H. Kollef, MD, professor of medicine and Virginia E. & Sam J. Golman chair of the Respiratory Intensive Care department of Washington University School of Medicine, discusses the current treatment options for Pseudomonas aeruginosa—piperacillin-tazobactam being the drug that is most commonly used in the United States. Dr. Kollef highlights other drugs that are also used for treatment, including cefcapene, aminoglycosides, and carbapenems. He also discusses 3 newer drugs available for the treatment of Pseudomonas infections.